Literature DB >> 2990670

The subpopulations and isolated cell types of freshly resected high grade human gliomas: their influence on the tumor's evolution in vivo and behavior and therapy in vitro.

J R Shapiro, W R Shapiro.   

Abstract

Human malignant gliomas are karyotypically heterogeneous, composed of many cellular populations and isolated cell types identifiable by cytogenetic techniques. The distributions of cell types vary in high grade tumors. Some tumors are primarily near-diploid (35-57 chromosomes per cell), while others are hyperdiploid with chromosome numbers ranging from 58 to several hundred chromosomes per cell. Regional studies of several tumors suggest that the heterogeneity is not random. Anatomically different regions result from the combination of cellular distribution and their evolution over time. The karyotypic pattern of gliomas also reflects the tumor's evolution from a relatively homogeneous population of near-diploid cells to the hyperdiploid tumor that is removed by the neurosurgeon. The in vitro studies also suggest that there are phenotypic correlates to the karyotypic pattern of the tumor cells. Hyperdiploid cells are unstable in culture, tend to grow rapidly with short doubling times, and are often sensitive to such chemotherapeutic agents as BCNU. In contrast, the near-diploid cells are more normal in appearance, are stable in culture, grow slowly with long doubling times, are more likely to be resistant to the nitrosoureas and ultimately are the 'stem' cells that repopulate the tumor mass.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2990670     DOI: 10.1007/bf00050691

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  48 in total

1.  Isolation of a cationic polypeptide from human serum that stimulates proliferation of 3T3 cells.

Authors:  H N Antoniades; D Stathakos; C D Scher
Journal:  Proc Natl Acad Sci U S A       Date:  1975-07       Impact factor: 11.205

2.  G-band analyses of an established cell line of a human malignant glioma.

Authors:  J Mark; J Pontén; B Westermark
Journal:  Humangenetik       Date:  1974

3.  Chromosome and chromosomal progression of human gliomas in vivo, in vitro and in athymic nude mice.

Authors:  S H Bigner; J Mark
Journal:  Prog Exp Tumor Res       Date:  1984

4.  Endomitosis: a reappraisal.

Authors:  E Therman; G E Sarto; P A Stubblefield
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

5.  Development of a clonogenic cell assay for human brain tumors.

Authors:  M L Rosenblum; D A Vasquez; T Hoshino; C B Wilson
Journal:  Cancer       Date:  1978-06       Impact factor: 6.860

6.  Comparative effects of human platelet growth factor on the growth and morphology of human fetal and adult diploid fibroblasts.

Authors:  J R Slayback; L W Cheung; R P Geyer
Journal:  Exp Cell Res       Date:  1977-12       Impact factor: 3.905

Review 7.  Properties of human malignant glioma cells in vitro.

Authors:  J Pontén; B Westermark
Journal:  Med Biol       Date:  1978-08

8.  Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequences encode the transforming gene product p28sis.

Authors:  S G Devare; E P Reddy; J D Law; K C Robbins; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

9.  Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma.

Authors:  S B Green; D P Byar; M D Walker; D A Pistenmaa; E Alexander; U Batzdorf; W H Brooks; W E Hunt; J Mealey; G L Odom; P Paoletti; J Ransohoff; J T Robertson; R G Selker; W R Shapiro; K R Smith; C B Wilson; T A Strike
Journal:  Cancer Treat Rep       Date:  1983-02

10.  Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23).

Authors:  J Whang-Peng; C S Kao-Shan; E C Lee; P A Bunn; D N Carney; A F Gazdar; J D Minna
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

View more
  18 in total

1.  Therapy-related chromosomal changes and cytogenetic heterogeneity in human gliomas.

Authors:  Y S Li; D A Ramsay; D R Macdonald; R F Del Maestro
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

2.  An isotope agarose assay for rapid testing of the sensitivity of glioma biopsies to chemotherapeutic drugs and biological response modifiers. Effects of BCNU, vincristine, lymphokines and the recombinant agents interferon alpha 2c, interferon gamma and tumour necrosis factor.

Authors:  G Unsgaard; E Helseth; R Vik; A Dalen
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

Review 3.  Cancer-initiating enriched cell lines from human glioblastoma: preparing for drug discovery assays.

Authors:  Miriam Romaguera-Ros; María Peris-Celda; Jorge Oliver-De La Cruz; Josefa Carrión-Navarro; Arantxa Pérez-García; Jose Manuel García-Verdugo; Angel Ayuso-Sacido
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

4.  Interaction between human brain tumour biopsies and fetal rat brain tissue in vitro.

Authors:  O Engebraaten; R Bjerkvig; M Lund-Johansen; K Wester; P H Pedersen; S Mørk; E O Backlund; O D Laerum
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

5.  Factor analysis of the immunophenotypes of astrocytomas and malignant gliomas: correlations with tumor grade and patient survival.

Authors:  M T Jennings; L L Asadourian; V D Jennings; J R Shapiro; H T Thaler
Journal:  J Neurooncol       Date:  1990-12       Impact factor: 4.130

6.  The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables.

Authors:  G Nikkhah; J C Tonn; O Hoffmann; H P Kraemer; J L Darling; W Schachenmayr; R Schönmayr
Journal:  J Neurooncol       Date:  1992-05       Impact factor: 4.130

7.  The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables.

Authors:  G Nikkhah; J C Tonn; O Hoffmann; H P Kraemer; J L Darling; R Schönmayr; W Schachenmayr
Journal:  J Neurooncol       Date:  1992-05       Impact factor: 4.130

8.  Chemotherapy for malignant gliomas of the brain: a review of ten-years experience.

Authors:  P Paoletti; G Butti; R Knerich; P Gaetani; R Assietti
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

9.  Genetic recombination in human melanoma and astrocytoma cell lines involves oncogenes and growth factor genes.

Authors:  M S Lakshmi; G V Sherbet
Journal:  Clin Exp Metastasis       Date:  1990 Jan-Feb       Impact factor: 5.150

10.  BCNU-sensitivity in parental cells and clones from four freshly resected near-diploid human gliomas: an astrocytoma, an anaplastic astrocytoma and two glioblastomas multiforme.

Authors:  J R Shapiro; S A Ebrahim; A N Mohamed; P Y Pu; W R Shapiro
Journal:  J Neurooncol       Date:  1993-03       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.